130 related articles for article (PubMed ID: 6271778)
1. Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D).
Lamp SJ; Findlay DM; Moseley JM; Martin TJ
J Biol Chem; 1981 Dec; 256(23):12269-74. PubMed ID: 6271778
[No Abstract] [Full Text] [Related]
2. Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells.
Schneider HG; Raue F; Koppold A; Ruf W; Ziegler R
Acta Endocrinol (Copenh); 1993 Apr; 128(4):373-8. PubMed ID: 8388616
[TBL] [Abstract][Full Text] [Related]
3. The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation.
Moseley JM; Findlay DM; Gorman JJ; Michelangeli VP; Martin TJ
Biochem J; 1983 Jun; 212(3):609-16. PubMed ID: 6309149
[TBL] [Abstract][Full Text] [Related]
4. Effects of pertussis toxin on adenylate cyclase responses to prostaglandin E2 and calcitonin in human breast cancer cells.
Michelangeli VP; Livesey SA; Martin TJ
Biochem J; 1984 Dec; 224(2):371-7. PubMed ID: 6097215
[TBL] [Abstract][Full Text] [Related]
5. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
[TBL] [Abstract][Full Text] [Related]
6. A new in vitro bioassay for human calcitonin: validation and comparison to the rat hypocalcemia bioassay.
Grauer A; Raue F; Reinel HH; Schneider HG; Schroth J; Kabay A; Brügger P; Ziegler R
Bone Miner; 1992 Apr; 17(1):65-74. PubMed ID: 1316197
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.
Findlay DM; Michelangeli VP; Eisman JA; Frampton RJ; Moseley JM; MacIntyre I; Whitehead R; Martin TJ
Cancer Res; 1980 Dec; 40(12):4764-7. PubMed ID: 6254651
[TBL] [Abstract][Full Text] [Related]
8. Interaction of adrenomedullin with calcitonin receptor in cultured human breast cancer cells, T 47D.
Disa J; Dang K; Tan KB; Aiyar N
Peptides; 1998; 19(2):247-51. PubMed ID: 9493856
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells.
Ng KW; Livesey SA; Larkins RG; Martin TJ
Cancer Res; 1983 Feb; 43(2):794-800. PubMed ID: 6184157
[TBL] [Abstract][Full Text] [Related]
10. Induction of adenylate cyclase in a mammary carcinoma cell line by human corticosteroid-binding globulin.
Nakhla AM; Khan MS; Rosner W
Biochem Biophys Res Commun; 1988 Jun; 153(3):1012-8. PubMed ID: 2839166
[TBL] [Abstract][Full Text] [Related]
11. Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line.
Findlay DM; deLuise M; Michelangeli VP; Martin TJ
J Endocrinol; 1981 Feb; 88(2):271-81. PubMed ID: 6259268
[TBL] [Abstract][Full Text] [Related]
12. Decrease in rat brain calcitonin binding sites and adenylyl-cyclase activity during ageing.
Villa I; Guidobono F; Netti C; Pecile A; Giovanazzi S; Nicosia S
Neuroreport; 1992 Jul; 3(7):601-4. PubMed ID: 1384767
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin receptors in a cloned human breast cancer cell line (MCF 7).
Martin TJ; Findlay DM; MacIntyre I; Eisman JA; Michelangeli VP; Moseley JM; Partridge NC
Biochem Biophys Res Commun; 1980 Sep; 96(1):150-6. PubMed ID: 6254504
[No Abstract] [Full Text] [Related]
14. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
D'Santos CS; Gatti A; Poyner DR; Hanley MR
Mol Pharmacol; 1992 May; 41(5):894-9. PubMed ID: 1375316
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D).
Findlay DM; Michelangeli VP; Moseley JM; Martin TJ
Biochem J; 1981 May; 196(2):513-20. PubMed ID: 7316992
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of selective activation of cyclic AMP-dependent protein kinase isoenzymes by calcitonin and prostaglandin E2 in human breast cancer cells.
Livesey SA; Collier G; Zajac JD; Kemp BE; Martin TJ
Biochem J; 1984 Dec; 224(2):361-70. PubMed ID: 6596096
[TBL] [Abstract][Full Text] [Related]
17. The calcitonin receptor: characterization and processing.
Raue F; Schneider HG; Ziegler R
Prog Clin Biol Res; 1990; 332():67-79. PubMed ID: 2158663
[No Abstract] [Full Text] [Related]
18. Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells.
Michelangeli VP; Findlay DM; Moseley JM; Martin TJ
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):129-41. PubMed ID: 6315797
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line.
Hunt NH; Ellison M; Underwood JC; Martin TJ
Br J Cancer; 1977 Jun; 35(6):777-84. PubMed ID: 194616
[TBL] [Abstract][Full Text] [Related]
20. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells.
Findlay DM; Martin TJ
Endocrinology; 1984 Jul; 115(1):78-83. PubMed ID: 6329663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
